Results 191 to 200 of about 370,724 (274)
Clinical Profile of RSV Breakthrough Infections After Nirsevimab Introduction. [PDF]
Vittucci AC +11 more
europepmc +1 more source
A PROTAC‐functionalized protein/DNA‐integrated nanoantigen platform is developed to enhance dendritic cell vaccine potency. By combining a VHL‐recruiting peptide‐modified antigen with a sustained expression plasmid within CaCO3 nanoparticles, this system amplifies cross‐presentation, promotes DC maturation, and elicits robust Th1 and CTL responses ...
Peng Liu +4 more
wiley +1 more source
Immunogenicity and Safety of a Single Booster Dose of Sabin-Strain Inactivated Poliovirus Vaccine in Adolescents and Adults: A Phase IV, Open-Label Trial. [PDF]
Zhang X +11 more
europepmc +1 more source
Borrelia afzelii, a major causative agent of Lyme borreliosis in Europe, exhibits extensive polymorphism at the ospC gene, which is hypothesized to be maintained by balancing selection. We investigated whether ospC shows reduced population structure compared with the putatively neutral rrs–rrl intergenic spacer (IGS) by analyzing B.
Józefina Wasilewska +2 more
wiley +1 more source
Shape of Yield Curves Under Instrument‐Based Parallel Shifts
ABSTRACT This paper studies the shape of zero and par yield curves through the carry and convexity of zero‐bond and par–swap butterflies under instrument‐based parallel shifts: the component instruments are held fixed, and each instrument's own quote receives the same additive shock.
Jian Sun
wiley +1 more source
Exploring barriers to the expanded programme on immunisation service utilisation in pastoralist communities of Afar, Afar Regional State, Ethiopia. [PDF]
Bilal MA, Netangaheni RT.
europepmc +1 more source
ABSTRACT Background and Aims Childhood immunization is a cost‐effective public health intervention, and Bangladesh has achieved South Asia's highest complete immunization rate, yet village‐level effectiveness of local awareness programs remains poorly evaluated.
Halima Khatun +2 more
wiley +1 more source
The gE+gI Lmix+CpG‐ODN 1018 vaccine was formulated by combining gE and gI mRNA/LNPs with the TLR9 agonist adjuvant CpG‐ODN 1018. This formulation induces robust humoral and cellular immunity while maintaining a favorable safety profile and physiological stability in mice.
Lingyan Cui +15 more
wiley +1 more source
ABSTRACT The cultural emphasis on mothers’ individual responsibility and choice regarding their children’s health is often considered a key factor behind vaccine hesitancy, especially among the middle class in Western countries. Drawing on qualitative interviews with vaccine‐hesitant Russian mothers, this article broadens this discussion in two ways ...
Ekaterina Borozdina
wiley +1 more source
Decision-making considerations for single-dose HPV vaccination, including drivers of schedule adoption or switch: insights from immunisation stakeholders in 19 low-income and middle-income countries. [PDF]
Rosser EN +6 more
europepmc +1 more source

